Challange
Generalized Myasthenia Gravis (gMG) is a rare, chronic autoimmune disorder characterized by muscle weakness and unpredictable symptom fluctuations. Despite advancements in therapy, a gap exists in clinician confidence and patient awareness regarding individualized dosing.
Similarly, only 15% of HCPs expressed strong confidence in discussing individualized dosing strategies. Further, clinicians reported significant challenges in selecting optimal treatment plans for newly diagnosed patients, navigating unfamiliar therapies, and recognizing delays in diagnosis.
Approach
Medlive, in collaboration with leading faculty and patient advocates, developed a CME/CE-certified, two-track educational initiative. The program utilized the Medlive Tethered framework to ensure integrated learning for both HCPs and patients. Educational formats included:
- HCP Education: A 60-minute live and on-demand curriculum featuring expert-led discussions, microlearning videos via LinkedIn, and data-driven insights into individualized dosing.
- Patient and Caregiver Education: A parallel 60-minute live and virtual program designed to increase awareness of treatment options and empower patients to engage in informed discussions with their providers.
Scope
- Landscape
- Challange
- Approach
- Results
The Results
“This program gave me the confidence to discuss individualized dosing with my patients in a way that is both evidence-based and practical. Understanding their concerns and aligning treatment strategies to their needs is key to improving outcomes. The patient insights were eye-opening—it’s clear that individualized approaches are not just beneficial but essential in managing gMG effectively.”
Dr. James Howard Jr.,
Professor of Neurology,
The University of North Carolina
at Chapel Hill
54
of clinicians intended to make a practice change based on the education received.
73
of patients planned to speak with their doctor about individualized dosing after the activity.
4,540
HCPs participated in the program, demonstrating broad engagement.
This activity was supported by an independent educational grant from argenx.
